190 related articles for article (PubMed ID: 20736378)
1. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
[TBL] [Abstract][Full Text] [Related]
2. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
[TBL] [Abstract][Full Text] [Related]
3. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
[TBL] [Abstract][Full Text] [Related]
5. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
6. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions.
Hashemi M; Etemad S; Rezaei S; Ziaolhagh S; Rajabi R; Rahmanian P; Abdi S; Koohpar ZK; Rafiei R; Raei B; Ahmadi F; Salimimoghadam S; Aref AR; Zandieh MA; Entezari M; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Feb; 158():114204. PubMed ID: 36916430
[TBL] [Abstract][Full Text] [Related]
7. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
Takahashi Y; Morales FC; Kreimann EL; Georgescu MM
EMBO J; 2006 Feb; 25(4):910-20. PubMed ID: 16456542
[TBL] [Abstract][Full Text] [Related]
8. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
9. Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.
Fenton TR; Nathanson D; Ponte de Albuquerque C; Kuga D; Iwanami A; Dang J; Yang H; Tanaka K; Oba-Shinjo SM; Uno M; Inda MM; Wykosky J; Bachoo RM; James CD; DePinho RA; Vandenberg SR; Zhou H; Marie SK; Mischel PS; Cavenee WK; Furnari FB
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14164-9. PubMed ID: 22891331
[TBL] [Abstract][Full Text] [Related]
10. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
11. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
[TBL] [Abstract][Full Text] [Related]
12. Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.
Waldron JS; Yang I; Han S; Tihan T; Sughrue ME; Mills SA; Pieper RO; Parsa AT
J Clin Neurosci; 2010 Dec; 17(12):1543-7. PubMed ID: 20822910
[TBL] [Abstract][Full Text] [Related]
13. Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status.
Memmel S; Sukhorukov VL; Höring M; Westerling K; Fiedler V; Katzer A; Krohne G; Flentje M; Djuzenova CS
PLoS One; 2014; 9(1):e87052. PubMed ID: 24498019
[TBL] [Abstract][Full Text] [Related]
14. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
[TBL] [Abstract][Full Text] [Related]
15. NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress.
Luo S; Lei K; Xiang D; Ye K
Oxid Med Cell Longev; 2018; 2018():9146528. PubMed ID: 30595797
[TBL] [Abstract][Full Text] [Related]
16. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma.
Wang Y; Wong CW; Yan M; Li L; Liu T; Or PM; Tsui SK; Waye MM; Chan AM
Cancer Lett; 2018 Aug; 429():54-65. PubMed ID: 29729901
[TBL] [Abstract][Full Text] [Related]
18. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
[TBL] [Abstract][Full Text] [Related]
19. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.
Park S; Zhao D; Hatanpaa KJ; Mickey BE; Saha D; Boothman DA; Story MD; Wong ET; Burma S; Georgescu MM; Rangnekar VM; Chauncey SS; Habib AA
Cancer Res; 2009 May; 69(10):4107-11. PubMed ID: 19435890
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells.
Li HF; Kim JS; Waldman T
Radiat Oncol; 2009 Oct; 4():43. PubMed ID: 19828040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]